Skip Nav Destination
An insertion mutation of ERBB2 enhances breast cancer cell growth and confers resistance to lapatinib through AKT signaling pathway
Biol Open (2020) 9 (1): bio047662.
This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.
- Peipei Shang
- Cheng Lou
- Lei Yin
- Chenjie Tao
- Yulong Dong
- Guang Yang
- Zhengang Yuan
Journal of International Medical Research (2023) 51 (11)
- Eva Valentina Klocker
- Christoph Suppan
Breast Care (2020) 15 (6): 586.